Genomic architecture differences at the HTT locus underlie symptomatic and pre-symptomatic cases of Huntington’s disease.
F1000Research |
Neuro/CNS
PSE boosts PSA accuracy from 55% to 94% for confirming the presence or absence of prostate cancer. The highly accurate blood test is simple to order by a physician and is available to men in the US and UK under the immediate access program.
Neuro/CNS
Cancer
Neuro/CNS
Neuro/CNS
Cancer
Autoimmune